Provided by Tiger Trade Technology Pte. Ltd.

Alkermes PLC

49.21
+0.34000.70%
Post-market: 49.210.00000.00%19:54 EDT
Volume:1.13M
Turnover:55.48M
Market Cap:8.26B
PE:126.75
High:49.58
Open:48.94
Low:48.87
Close:48.87
52wk High:55.67
52wk Low:25.17
Shares:167.76M
Float Shares:155.00M
Volume Ratio:0.88
T/O Rate:0.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3882
EPS(LYR):1.43
ROE:3.85%
ROA:4.20%
PB:4.56
PE(LYR):34.41

Loading ...

Alkermes Q2 Earnings Flat, Revenue Rises; Reiterates 2026 Revenue Guidance

MT Newswires Live
·
Jul 28

Earnings Flash (ALKS) Alkermes Posts Q2 Revenue $496M, vs. FactSet Est of $457.4M

MT Newswires Live
·
Jul 28

Alkermes Q2 Sales $496.009M Beat $457.818M Estimate

Benzinga Earnings
·
Jul 28

Press Release: Alkermes Plc Reports Second Quarter 2026 Financial Results

Dow Jones
·
Jul 28

Alkermes Plc : Piper Sandler Raises Target Price to $65 from $43

THOMSON REUTERS
·
Jul 28

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 27

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Celldex (CLDX)

TIPRANKS
·
Jul 25

Does Sustained Alixorexton Data in Narcolepsy Reshape The Bull Case For Alkermes (ALKS)?

Simply Wall St.
·
Jul 25

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 24

Alkermes Plc : Leerink Partners Raises Target Price to $50 from $34

THOMSON REUTERS
·
Jul 21

Earning Preview: Alkermes PLC Q2 revenue expected to increase by 33.98%, institutions tilt positive on near-term revenue resilience

Earnings Agent
·
Jul 21

Alkermes Plc : Stifel Raises Target Price to $63 from $45

THOMSON REUTERS
·
Jul 20

Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY) and Alkermes (ALKS)

TIPRANKS
·
Jul 20

Alkermes Schedules Second-quarter Results Call and Webcast

Reuters
·
Jul 15

Alkermes to Report Second Quarter Financial Results on July 28, 2026

THOMSON REUTERS
·
Jul 15

Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Jul 14

Alkermes Plc : TD Cowen Raises Target Price to $57 from $50

THOMSON REUTERS
·
Jul 13

Alkermes Price Target Announced at $60.00/share by JP Morgan

Dow Jones
·
Jul 13

Alkermes Says Alixorexton Sustains Wakefulness Gains in Nine-month Narcolepsy Extension Study Interim Analysis

Reuters
·
Jul 13

Alkermes - Alixorexton Generally Well Tolerated at All Doses Tested

THOMSON REUTERS
·
Jul 13